Logo for Shield Therapeutics plc

Shield Therapeutics Investor Relations Material

Latest events

Logo for Shield Therapeutics plc

Trading Update

Shield Therapeutics
Logo for Shield Therapeutics

Trading Update

6 Feb, 2025
Logo for Shield Therapeutics

Corporate Presentation

4 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Shield Therapeutics plc

Access all reports
Shield Therapeutics plc is a specialty pharmaceutical company focused on the development and commercialization of treatments for iron deficiency and related conditions. The company's lead product, Accrufer/Feraccru® (ferric maltol), is an oral iron therapy designed to treat iron deficiency in patients who cannot tolerate traditional iron supplements. Shield Therapeutics operates in Europe and the United States, partnering with healthcare providers and pharmaceutical distributors to expand its market reach. The company is headquartered in Gateshead, United Kingdom, and its shares are listed on the AIM.